ZNF384 and precursor B-cell acute lymphoblastic leukemia: However, they have unique associations with immunophenotypes (e.g., 85.7% of ZNF384 rearrangements are concentrated in pre-B-ALL) and potential pathogenic mechanisms (e.g., ZNF384 regulates PAX5 to affect B-cell differentiation).